Pharmacotherapy of the overactive bladder and advances in drug delivery

被引：23
作者：
Cannon, TW [1 ]
Chancellor, MB [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
CLINICAL OBSTETRICS AND GYNECOLOGY | 2002年 / 45卷 / 01期
关键词：
D O I：
10.1097/00003081-200203000-00022
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：205 / 217
页数：13
相关论文
共 37 条
  • [31] Genitourinary tract patent update
    Smith, CP
    Chancellor, MB
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (01) : 17 - 31
  • [32] SZALLASI A, 1990, PAIN, V30, P571
  • [33] THOR KB, 1995, J PHARMACOL EXP THER, V274, P1014
  • [34] Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder
    Van Kerrebroeck, P
    Kreder, K
    Jonas, U
    Zinner, N
    Wein, AN
    [J]. UROLOGY, 2001, 57 (03) : 414 - 421
  • [35] Pharmacologic options for the overactive bladder
    Wein, AJ
    [J]. UROLOGY, 1998, 51 (2A) : 43 - 47
  • [36] The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results
    Wiart, L
    Joseph, PA
    Petit, H
    Dosque, JP
    de Seze, M
    Brochet, B
    Deminiere, C
    Ferriere, JM
    Mazaux, JM
    N'Guyen, P
    Barat, M
    [J]. SPINAL CORD, 1998, 36 (02) : 95 - 99
  • [37] Yu YB, 1999, J PHARMACOL EXP THER, V290, P825
1234